Replies to post #659609 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

That the CHM meeting will happen on schedule. Personally, I don’t think there will be any issues.

[dennisdave]

It means that on 21 and 22 March 2024 the CHM will decide if they approve DCVAXL or more likely they have additional questions. In case of the latter NWBO will be then granted a 60-day max timeline to answer the questions asked by the MHRA which would bring the deadline for NWBO to answer to around May 26, 2024. Then 70 days later on August 4, 2024, the MHRA should decide on MHRA approval for DCVAXL in the UK.